Chargement en cours...

Paradoxical Effect of TrkA Inhibition in Alzheimer’s Disease Models

An unbiased screen for compounds that block amyloid-β protein precursor (AβPP) caspase cleavage identified ADDN-1351, which reduced AβPP-C31 by 90%. Target identification studies showed that ADDN-1351 is a TrkA inhibitor, and, in complementary studies, TrkA overexpression increased AβPP-C31 and cell...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Zhang, Qiang, Descamps, Olivier, Hart, Matthew J., Poksay, Karen S., Spilman, Patricia, Kane, Darci J., Gorostiza, Olivia, John, Varghese, Bredesen, Dale E.
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4091737/
https://ncbi.nlm.nih.gov/pubmed/24531152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-130017
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!